Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients

Area of Science:

• Nephrology
• Endocrinology
• Cardiology

Background:

• The prevalence and impact of thyroid disorders on cardiovascular events and mortality in dialysis patients remain largely unknown.
• This study investigated the association between subclinical thyroid disorders and cardiovascular outcomes in patients undergoing hemodialysis.

Purpose of the Study:

• To determine if subclinical thyroid disorders are associated with cardiovascular events and mortality in diabetic hemodialysis patients.
• To analyze the short-term and long-term effects of thyroid status on cardiovascular outcomes.

Main Methods:

• A prospective, multicenter cohort study involving 1,000 diabetic hemodialysis patients.
• Thyroid status was categorized into euthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, and euthyroid sick syndrome based on TSH, free T3, and free T4 levels.
• Cardiovascular events and mortality were tracked over a 4-year follow-up period.

Main Results:

• Euthyroidism was observed in 78.1% of patients, subclinical hyperthyroidism in 13.7%, subclinical hypothyroidism in 1.6%, and euthyroid sick syndrome in 5.4%.
• Short-term analysis revealed a doubled risk of sudden cardiac death in patients with subclinical hyperthyroidism and euthyroid sick syndrome.
• Euthyroid sick syndrome was associated with a nearly threefold increased short-term mortality risk, but this effect diminished long-term. Subclinical hypothyroidism did not show significant associations with cardiovascular events or mortality.

Conclusions:

• Subclinical hyperthyroidism and euthyroid sick syndrome may increase the short-term risk of sudden cardiac death in hemodialysis patients.
• Euthyroid sick syndrome is a significant predictor of mortality in this patient group.
• Regular monitoring of thyroid status in dialysis patients could aid in assessing cardiac risk.